Everything below concerns angiotensin IV. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is not approved for human use in the United States or the European Union. It is commonly sold as a research chemical, a category that may not require the same regulatory review as medicines. Buyers should note that product labels may lack independent verification of identity or purity. The legal status can vary by country, and importation may be restricted. Reliable information about sourcing and quality is often scarce. Scientific publications typically use synthesized material from laboratories rather than commercial consumer products.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Note that the cool air in the refrigerator or freezer is still warmer than the refrigerant in the evaporator. Refrigerant leaves the evaporator, now fully vaporized and slightly heated, and returns to the compressor inlet to continue the cycle. Modern domestic refrigerators are extremely reliable because motor and compressor are integrated within a welded container, "sealed unit", with greatly reduced likelihood of leakage or contamination. By comparison, externally-coupled refrigeration compressors, such as those in automobile air conditioning, inevitably leak fluid and lubricant past the shaft seals. This leads to a requirement for periodic recharging and, if ignored, possible compressor failure.
When urine pH is abnormal, the urinary recovery of amphetamine may range from a low of 1% to a high of 75%, depending mostly upon whether urine is too basic or acidic, respectively. Following oral administration, amphetamine appears in urine within 3 hours. Roughly 90% of ingested amphetamine is eliminated 3 days after the last oral dose. CYP2D6, dopamine β-hydroxylase (DBH), flavin-containing monooxygenase 3 (FMO3), butyrate-CoA ligase (XM-ligase), and glycine N-acyltransferase (GLYAT) are the enzymes known to metabolize amphetamine or its metabolites in humans. Amphetamine has a variety of excreted metabolic products, including 4-hydroxyamphetamine, 4-hydroxynorephedrine, 4-hydroxyphenylacetone, N-hydroxyamphetamine, benzoic acid, hippuric acid, norephedrine, and phenylacetone. Among these metabolites, the active sympathomimetics are 4-hydroxyamphetamine, 4-hydroxynorephedrine, norephedrine, and N-hydroxyamphetamine. The main metabolic pathways involve aromatic para-hydroxylation, aliphatic alpha- and beta-hydroxylation, N-oxidation, N-dealkylation, and deamination. The known metabolic pathways, detectable metabolites, and metabolizing enzymes in humans include the following:
== Products == ELGA produces water purification systems which provide purified water and ultrapure water for applications in research and analytical laboratories, medical and clinical facilities. It incorporates in its water purifiers a combination of purification technologies, e.g. reverse osmosis, electronics-grade ion-exchange resins, microfiltration, ultrafiltration, degassing, ultraviolet photooxidation and electrodeionization. Products are designed to minimize impact on the environment at all stages - manufacture, in-service and at end of life.
Sources: en.wikipedia.org
Animals have several characteristics that they share with other living things. Animals are eukaryotic, multicellular, and aerobic, as are plants and fungi. Unlike plants and algae, which produce their own food, animals cannot produce their own food, a feature they share with fungi. Animals ingest organic material and digest it internally.
=== Development === In 2000, Danny McBride met Len Wiseman through Nick Reed, who was the agent for both of them with intent for them to work together on a script the former wrote. While the plans for that film fizzled out, they did set out a plan to work together. Kevin Grevioux had graduated from Howard University with a degree in microbiology, but he developed a desire to study film in cinematography and screenwriting. He dropped out of graduate studies and moved to Los Angeles, where he became an actor. He came up with the original concept for the film and wrote the original screenplay, which was inspired by Romeo and Juliet alongside his college studies, which based vampirism and lycanthropy on a viral mutagen rather than mythology. McBride and Wiseman soon stepped in to work on the script, which they soon set out to make a trilogy of films. Each received credit for their work on the film, and Grevioux also appeared in the film as an actor.
Most rattlesnake species mate during the summer or fall, while some species mate only in the spring, or during both the spring and fall. Females secrete small amounts of sex pheromones, which leave a trail the males follow using their tongues and Jacobson's organs as guides. Once a receptive female has been located, the male often spends several days following her around (a behavior not common outside of the mating season), frequently touching and rubbing her in an attempt to stimulate her. The males of some species, such as timber rattlesnakes (C. horridus), fight each other during the mating season, in competition over females. These fights, known as "combat dances", consist of the two males intertwining the anterior portion of their bodies, often with their heads and necks held vertically. The larger males usually end up driving the smaller males away. Although many kinds of snakes and other reptiles are oviparous (lay eggs), rattlesnakes are ovoviviparous (give birth to live young after carrying eggs inside). The female produces the ova ("eggs") in her ovaries, after which they pass through her body cavity and into one of her two oviducts. The ova are arranged in a continuous chain in a coiled section of the oviduct, known as the "tuba". Male rattlesnakes have sexual organs known as hemipenes, located in the base of the tail. The hemipenis is retracted inside of the body when mating is not occurring. The hemipenis is similar to the human penis.
Sources: en.wikipedia.org
While the exact end date of the Cold War is debated among historians, it is generally agreed upon that the implementation of nuclear and conventional arms control agreements, the withdrawal of Soviet military forces from Afghanistan and Eastern Europe, and the resultant collapse of the Soviet Union marked the end of the Cold War. Scholars remain divided over the underlying causes, with materialist accounts emphasizing Soviet economic decline and ideational accounts stressing the personal worldviews of Gorbachev and Reagan coupled with the broader appeal of the Western European model.
Louisiana governor Jeff Landry requested the deployment of the National Guard for large upcoming events: the Bayou Classic college football event November 27–29, New Year Eve and Day celebrations, and Mardi Gras celebrations in February. The New Orleans police superintendent said, "We are working together and planning their deployment." New Orleans had been the site of the January 1, 2025, terrorism attack in which 14 persons lost their lives and at least 57 persons were injured.
In October 2020, GSK told some staff that while at work they should disable the contact tracing function of the NHS test-and-trace app which monitors the spread of COVID-19. GSK explained the reason for this was due to social distancing measures in place at their sites rendering the technology unnecessary. In November 2023, GSK filed a lawsuit against Moderna Inc. in U.S. federal court in Delaware, accusing the company of violating GSK's patents related to messenger RNA (mRNA) technology. The lawsuit claims that Moderna's COVID-19 vaccine Spikevax and RSV vaccine mResvia infringe on several of GSK's patents, particularly those related to lipid nanoparticles used for delivering mRNA into the human body. This legal action follows a similar lawsuit GSK filed against Pfizer and BioNTech earlier in 2024, also over patent infringement concerning their mRNA-based COVID-19 vaccine. The current litigation seeks unspecified monetary damages from Moderna.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.